Search - tctmd.com

Displaying 121 - 140 of 173

Sort: Relevancy | Date

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Industry News

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

September 14, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

News Daily News

Heart Block Itself Does Not Worsen Prognosis After AMI

Caitlin E. Cox

October 10, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Daily News

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Todd Neale

August 07, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

August 02, 2013

Advertisement

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

Heart Block Itself Does Not Worsen Prognosis After AMI

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content